NUS Researchers Lead Groundbreaking Analysis on Regional CVD Trends

The National University of Singapore has positioned itself at the forefront of public health research with a comprehensive study forecasting the trajectory of cardiovascular disease across Asia. Led by experts from the Yong Loo Lin School of Medicine and the National University Heart Centre Singapore, this work highlights the alarming escalation in Southeast Asia, where the number of individuals affected by cardiovascular conditions has already climbed dramatically over recent decades. This initiative underscores Singapore's universities commitment to tackling pressing regional health challenges through data-driven insights.

Cardiovascular disease, encompassing conditions like ischemic heart disease, stroke, and hypertensive heart disease, has transitioned from a secondary concern to the dominant cause of mortality in many Southeast Asian nations. The analysis draws on vast datasets to project future burdens, emphasizing the need for proactive strategies in prevention and treatment.

Historical Surge: 148% Increase in Southeast Asia Over Three Decades

From 1990 to 2021, Southeast Asia witnessed an 86.4% rise in crude prevalence of cardiovascular disease, with crude mortality increasing by 82.0%. While age-standardized rates showed improvement, with mortality dropping 27.4%, the sheer population growth amplified the absolute numbers, marking a near 150% surge in affected individuals. Ischemic heart disease emerged as the primary killer, responsible for 82 deaths per 100,000 population in age-standardized terms by 2021.

This trend reflects broader shifts in lifestyle, urbanization, and aging demographics across countries like Indonesia, Thailand, Vietnam, and the Philippines. In Singapore, parallel patterns are evident, with cardiovascular conditions accounting for over 30% of deaths as of recent national data.

Projections to 2050: Stark Warnings for Southeast Asia

Looking ahead from 2025 to 2050, Southeast Asia faces a projected 81.7% increase in crude prevalence, 86.2% in crude deaths, and 66.9% in crude disability-adjusted life years. Even as age-standardized metrics improve—prevalence down 11.5%, deaths 30.7%, DALYs 33.6%—the raw burden will strain healthcare systems. By mid-century, cardiovascular mortality could contribute significantly to Asia's overall 91.2% crude rise to 24.1 million deaths continent-wide.

These forecasts utilize Bayesian age-period-cohort models on Global Burden of Disease data, accounting for population dynamics and historical patterns. For context, Singapore's own projections from complementary NUS research indicate heart attacks tripling to 1,418 per 100,000 by 2050, driven by metabolic shifts.

Key Risk Factors Fueling the Epidemic

High systolic blood pressure remains the top attributable risk, but high body mass index is surging fastest, poised to overtake as the dominant factor by 2050 in line with Singapore-specific models. Other contributors include high fasting plasma glucose, air pollution, and dietary risks. Behavioral factors like tobacco use and low physical activity persist, while environmental stressors exacerbate vulnerabilities in rapidly urbanizing areas.

• High BMI: Projected to drive disproportionate increases in ischemic heart disease.
• Hypertension: Still leading but aging populations amplify impact.
• Diabetes (high FPG): Closely linked to metabolic syndrome prevalent in the region.
• Air pollution: Urban centers like Jakarta and Manila face compounded exposure.

Singapore's experience mirrors this, with obesity-related acute myocardial infarction deaths forecasted to quadruple.

Singapore's Context: A Microcosm of Regional Challenges

In Singapore, cardiovascular disease claims nearly one in three lives, with recent government reports noting policy reviews to bolster prevention. The Ministry of Health's 2026 updates highlight expanded community rehabilitation and screening. Heart attacks, strokes, and related conditions dominate, with projections aligning with Southeast Asian trends but tempered by advanced healthcare infrastructure.

National initiatives emphasize early detection, yet rising obesity—expected to fuel 880% growth in heart attack risks—demands innovation. Universities play a pivotal role, translating data into actionable interventions.

NUS's Pivotal Role in Cardiovascular Research

The Yong Loo Lin School of Medicine at NUS anchors much of this effort, with researchers like Rachel Sze Jen Goh, Bryan Chong, and Nicholas WS Chew spearheading analyses. Their work integrates epidemiology, biostatistics, and clinical insights from the National University Heart Centre. Complementary efforts include the Cardiovascular-Metabolic Disorders Translational Research Programme, focusing on prevention.

NUS collaborates regionally, informing policies across ASEAN. Faculty expertise spans from AI-driven risk prediction to genomic studies, fostering multi-disciplinary teams.

Innovative Initiatives: Project RESET and Beyond

Launched in 2023, Project RESET—spearheaded by NUS Medicine, NUHS, and partners—recruits thousands for early heart disease markers using advanced imaging and biomarkers. Aimed at preventing the projected surge, it employs AI for metabolism, heart, and liver health analysis.

Duke-NUS Medical School contributes via its CVMD programme, exploring metabolic-cardio links. NTU's Lee Kong Chian School integrates engineering for wearables and diagnostics. These efforts position Singapore universities as hubs for translational research.

Stakeholder Perspectives and Expert Insights

Clinicians at National Heart Centre Singapore stress lifestyle interventions, while policymakers advocate subsidies for rehab. Regional experts note equity gaps, with low-income groups hit hardest. NUS academics call for targeted family-based programs and youth empowerment in health leadership.

Industry partners like NOVI Health and international collaborators amplify impact, blending academia with practice.

Challenges in Addressing the Surge

Urbanization accelerates risks, with air pollution and sedentary jobs prominent. Aging populations strain resources, while disparities affect ethnic minorities like Malays and Indians in Singapore. Data gaps in rural Southeast Asia hinder precise modeling.

Universities face funding pressures but secure grants for AI and genomics. Workforce shortages in cardiology necessitate training expansions.

Solutions and Actionable Strategies from Academia

NUS-led models advocate primary prevention: BMI management, BP screening, pollution mitigation. Step-by-step approaches include community education, digital tools for monitoring, and policy for active transport.

• Enhance school programs on nutrition and exercise.
• Deploy AI for risk stratification in clinics.
• Foster ASEAN research networks for data sharing.
• Expand rehab via telehealth.

Singapore's Health Promotion Board partners with universities for campaigns.

Photo by Kara Nash on Unsplash

Future Outlook and Opportunities in Research Careers

By 2050, Southeast Asia's CVD burden demands innovation, offering roles in epidemiology, AI health tech, and policy. NUS and peers provide PhD programs, postdocs, faculty positions in cardio-metabolic fields. Explore research jobs or Singapore academic opportunities.

Optimism lies in declining age-std rates, but crude rises necessitate urgency. Singapore universities lead, training next-gen experts for regional impact.